Sudershan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 7.53 M
as on 17-12-2024
- Company Age 25 Year,
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 26.30 Cr
as on 17-12-2024
- Revenue 26.79%
(FY 2023)
- Profit -100.22%
(FY 2023)
- Ebitda 39.85%
(FY 2023)
- Net Worth -0.26%
(FY 2023)
- Total Assets -22.13%
(FY 2023)
About Sudershan Laboratories
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.53 M.
The company has closed loans amounting to ₹26.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Appala Chilakanarri, Zia Ansari, and Farah Gokaraju serve as directors at the Company.
- CIN/LLPIN
U24230TG2000PLC033330
- Company No.
033330
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sudershan Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Appala Chilakanarri  | Director | 29-Sep-2020 | Current |
| Zia Ansari | Director | 26-Feb-2021 | Current |
| Farah Gokaraju | Director | 29-May-2000 | Current |
Financial Performance of Sudershan Laboratories.
Sudershan Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.79% increase. The company also saw a substantial fall in profitability, with a 100.22% decrease in profit. The company's net worth dipped by a decrease of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sudershan Laboratories?
In 2023, Sudershan Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gr Intrachem LimitedActive 23 years 8 monthsAppala Chilakanarri, Zia Ansari and 1 more are mutual person
- Sudershan Drugs And Intermediates LimitedActive 42 years 22 days
Appala Chilakanarri is a mutual person
- Gr Cheminn Pharma Private LimitedActive 24 years 2 months
Zia Ansari and Farah Gokaraju are mutual person
- Imperial Projects India Private LimitedActive 18 years 9 months
Zia Ansari and Farah Gokaraju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 25 Jul 2009 | ₹12.30 Cr | Satisfied |
Uco Bank Creation Date: 27 Sep 2000 | ₹14.00 Cr | Satisfied |
How Many Employees Work at Sudershan Laboratories?
Sudershan Laboratories has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sudershan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudershan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
